Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
about
Proteome-wide lysine acetylation in cortical astrocytes and alterations that occur during infection with brain parasite Toxoplasma gondiiADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic propertiesThe potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosisGrowth and repair factors, osteoactivin, matrix metalloproteinase and heat shock protein 72, increase with resolution of inflammation in musculotendinous tissues in a rat model of repetitive graspingMutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein.Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.Silencing of GPNMB by siRNA inhibits the formation of melanosomes in melanocytes in a MITF-independent fashionGene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic ArthritisMutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast FunctionMolecular genetic studies of gene identification for osteoporosis: the 2009 updateComprehensive characterization of mesenchymal stem cells from human placenta and fetal membrane and their response to osteoactivin stimulation.Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer.Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex VivoBeneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitisIdentification of microRNAs changed in the neonatal lungs in response to hyperoxia exposure.Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer.Osteoactivin (GPNMB) ectodomain protein promotes growth and invasive behavior of human lung cancer cells.Management of metastatic breast cancer with second-generation antibody-drug conjugates: focus on glembatumumab vedotin (CDX-011, CR011-vcMMAE).High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma.Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease.IL15RA is required for osteoblast function and bone mineralization.Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma.Prospects of osteoactivin in tissue regeneration.Osteoactivin promotes osteoblast adhesion through HSPG and αvβ1 integrin.Osteoactivin induces transdifferentiation of C2C12 myoblasts into osteoblasts.Osteoactivin inhibition of osteoclastogenesis is mediated through CD44-ERK signalingExpression and immunolocalization of Gpnmb, a glioma-associated glycoprotein, in normal and inflamed central nervous systems of adult ratsGPNMB Induces BiP Expression by Enhancing Splicing of BiP Pre-mRNA during the Endoplasmic Reticulum Stress Response.Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) and Cancer: A Novel Potential Therapeutic Target.Antibody-Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments.Transdifferentiation of myoblasts into osteoblasts - possible use for bone therapy.Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.Genetically engineered mesenchymal stem cells: The ongoing research for bone tissue engineering.Loss of GPNMB Causes Autosomal-Recessive Amyloidosis Cutis Dyschromica in Humans.GPNMB enhances bone regeneration by promoting angiogenesis and osteogenesis: potential role for tissue engineering bone.Glycoprotein nonmetastatic B as a prognostic indicator in small cell lung cancer.The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor.Homeodomain transcription factors regulate BMP-2-induced osteoactivin transcription in osteoblasts.
P2860
Q22255525-B2CE481C-4E32-42F6-ACD2-7EE7F8AE8F58Q27321658-0DA73A60-ECCE-4D37-B4A7-11B754FFBA6AQ28117892-FAE1E983-1D5D-4DFD-BABF-A5B54036751DQ28384478-A4B9EAAE-FD5A-4143-AD5D-C26A988FFB32Q30417516-2E932F5C-F450-4B01-9C68-2DB9F5FC8572Q33891014-3CB1C512-5775-476B-95F0-C7E113974AE6Q34247178-BE3B602C-B648-4660-B86D-7AFDBF6EA6E0Q34389108-C7E56812-920F-4B43-8D04-D4BB234F999AQ35667354-23F59969-CDB7-48E0-AF1A-0FE8A2482B59Q35953074-9E6904A0-8855-4E3E-9473-ED7CE9F989E0Q36003387-7B32F124-2703-48B9-851D-7D680A692ACFQ36026788-FBC9E7CF-C0CD-4CBD-B13B-EDF6CAF7BBB2Q36051772-1E7F295B-8FE5-41A6-9EC8-9CBE7258CA2CQ36103227-C24CF3BA-3D6F-4CE1-8F79-BA1AE05B55E0Q36298216-20C6B01B-7797-4DBC-B8EE-A4BC20CB5C1BQ36320733-CBC1C9D8-9E85-45BE-A628-5958C8DDE2A6Q37014479-A6DFAFE3-4545-4BF4-B535-34456C453B31Q37046492-4B6B7C9C-EC93-4A3A-802A-4867BBDAE1B5Q38185304-414178CE-2869-4110-A609-005253554521Q38654361-73B9CCC3-330A-484F-B816-37BA5AE96BCDQ38693732-42CFF63E-9641-49FF-8090-305373E69F3EQ38700649-543F24E0-749E-487F-85A4-4E594E11EE61Q38814412-5E273F23-745E-4B1A-A0A5-2C38BE4C6B87Q38840985-D5A6788A-8AA7-4E0A-AF63-3E8E7064EA3AQ38843273-1458897C-A9D4-4900-AD44-ED7104D84698Q39035204-55D05781-AFB5-4B25-B2AE-2BB930893144Q39058566-643C416C-2C90-4AA7-BAFC-0DFD845DB37AQ39431450-B2EEBDFC-5B6C-494C-8524-7261F928564AQ42002720-EE3B4ADE-0043-40B1-B3C2-089FE9719C01Q42362892-8B806BB4-08FA-4A0A-ABD5-4EFE5D570D9FQ47448408-FBD0A9AE-E724-4119-9ED4-6769387CC0F1Q47851750-EDCBB11B-A657-4729-98A4-2DDB8858D2EEQ47951257-BAC9E0B8-D72A-49BF-869F-64336F064FE9Q48125956-25672099-BD1B-4192-834A-A4F0C00A89CEQ48828725-2843C75A-9DC3-4FB7-AD3B-184DD4EC8513Q50034858-EC9AD0EB-E611-4A4B-98AE-E1B609CED55BQ50883871-F4FB4AFE-AFC0-4C24-B7B5-C4560AE49C66Q51010443-091E22C8-58C7-487E-97F8-25F668C489E3Q51764776-A46599F5-7311-47B7-A32B-051300778733Q52610201-0FD181A1-8626-41CE-9900-88C0B0CB2FE7
P2860
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
@ast
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
@en
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
@en-gb
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
@nl
type
label
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
@ast
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
@en
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
@en-gb
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
@nl
prefLabel
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
@ast
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
@en
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
@en-gb
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
@nl
P2093
P3181
P1476
Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
@en
P2093
I ARANGOHISIJARA
M ANDERSON
S ABDELMAGID
S SALIHOGLU
P2880
P304
P3181
P356
10.1016/J.YEXCR.2008.02.006
P407
P577
2008-08-01T00:00:00Z